More on AGEN
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $7.85 |
|
|||
| Open | $7.80 | ||||
| 52 Wk High | $7.49 | ||||
| 52 Wk Low | $2.61 | ||||
| Day High | $8.60 | ||||
| Day Low | $7.60 | ||||
| P/E | N/A | ||||
| EPS | $-1.10 | ||||
| Volume | 1,299,719 | ||||
- Chardan Starts Agenus Inc. (AGEN) at Buy
- Form 4 AGENUS INC For: Aug 05 Filed by: Marcucci Marco Tullio
- Form 3 AGENUS INC For: Aug 05 Filed by: Marcucci Marco Tullio
- Form S-3 AGENUS INC
- Agenus to Present Three-Year Overall Survival Data for BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026
- Agenus drug combo shows 33% three-year survival in colorectal cancer
- Agenus Announces Peer-Reviewed Publication Linking BOT+BAL’s Durable Survival in MSS Metastatic Colorectal Cancer to Its Distinct Immune-Priming Mechanism
- Agenus reports no recurrences in Phase 2 colon cancer drug trial
- Agenus Announces Updated NEST Phase 2 Publication Reporting Deep Pathologic Responses and No Observed Recurrences with Neoadjuvant BOT+BAL in Resectable Colon Cancer
- Form 8-K AGENUS INC For: Aug 12
Entities mentioned with AGEN
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
